Will Nectome have a legally separate nonprofit dedicated to storing patients by the end of the year?
SportOne-OffGesundheit & MedizinSchach2MonManifold MarketsKein KYCVerifizierte AuflösungsdatenOrdentlich kalibriertAktuelle Community-PrognoseJa 70.1%
Prognostiker
12
Fragetyp
binary
Methodik
Play-money forecasting platform
Quellentyp
Prognose
Marktdaten
Aktualisiert vor 10 Minuten
18. März 26, 22:53 UTC31. Dez. 26, 23:59 UTC
Trends
Verwandte Märkte
Verwandte Fragen als Kontext, kein Vergleich gleichwertiger Kontrakte.
Does Nectome's preservation protocol work?
Manifold MarketsWill Leffen ever win another Major? (Melee)
Manifold MarketsWill Ice Cream turn out to actually be "healthy" based on consensus view at EOY 2026?
Manifold MarketsDid Lyme disease come from a laboratory?
Manifold MarketsWill psilocybin remain Schedule I through the end of 2027?
Manifold MarketsPrime Minister of Israel after the 2026 election?
KalshiRegeln
Brain preservation company Nectome is looking to start taking patients this year.
- Their chief of operations claims "90% confidence on [being able to preserve people by] December 2026". https://www.lesswrong.com/posts/E9xfgJHvs6M55kABD/less-dead?commentId=fkSjPfqybvNJffPs3
- Their founder said: "I think Alcor got it right when they designed their system for long-term care of people.
- They use a separate company to actually hold preserved people, so that if Alcor (the entity doing perservations) goes out of business, Alcor (the separate entity holding preserved people) continues its operations.
- Startups fail all the time because they take risks and are doing new things.
- But graveyards fail much less often, because they get initial endowments and have very predictable costs and few people to pay.
